Prognostic significance of systolic blood pressure changes during dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain and known or suspected coronary artery disease

American Journal of Cardiology

Volumn 79, Issue 8, 1997, Pages 1031-1035

  Geleijnse, Marcel L ^a   Elhendy, Abdou ^b   Van Domburg, Ron T ^b   Rambaldi, Riccardo ^b   Reijs, Ambroos E M ^b   Roelandt, Jos R T C ^b   Fioretti, Paolo M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SPHYGMOMANOMETRY; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-AGONISTS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATROPINE; BLOOD PRESSURE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DOBUTAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; SYSTOLE; TECHNETIUM TC 99M SESTAMIBI;

EID: 0030988230     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00042-8     Document Type: Article

References (28)

1. Günalp B, Dokumaci B, Uyan C, Vardareli E, Isik E, Bayhan H, Özgüven M, Öztürk E. Value of dobutamine technetium-99m-sestamibi SPECT and echocardiography in the detection of coronary artery disease compared with coronary angiography. J Nucl Med 1993;34:889-894.
2. Marwick T, D'Hondt A, Baudhuin T, Willemart B, Wijns W, Detry JM, Melin J. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993;22:159-167.
3. Herman SD, Labresh KA, Santos-Ocampo CD, Garber CE, Barbour MM, Messinger DE, Cloutier DJ, Ahlberg AW, Heller GV. Comparison of dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery disease. Am J Cardiol 1994;73:164-169.
4. Senior R, Sridhara BS, Anagnostou E, Handler C, Raftery EB, Lahiri A. Synergistic value of simultaneous stress dobutamine sestamibi single-photon emission computerized tomography and echocardiography in the detection of coronary artery disease. Am Heart J 1994;128:713-718.
5. Voth E, Baer FM, Theissen P, Schneider CA, Sechtem U, Schicha H. Dobutamine 99m-Tc-MIBI single-photon emission tomography: non-exercise-dependent detection of haemodynamically significant coronary artery stenoses. Eur J Nucl Med 1994;21:537-544.
6. Geleijnse ML, Elhendy A, van Domburg RT, Cornel JH, Reijs AEM, Roelandt JRTC, Krenning EP, Fioretti PM. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol 1996;28:447-454.
7. Hammermeister KE, DeRouen TA, Dodge HT, Zia M. Prognostic and predictive value of exertional hypotension in suspected coronary heart disease. Am J Cardiol 1983;51:1261-1266.
8. Sanmarco ME, Pontius S, Selvester RH. Abnormal blood pressure response and marked ischemic ST-segment depression as predictors of severe coronary artery disease. Circulation 1980;61:572-578.
9. Weiner DA, McCabe CH, Ryan TJ. Prognostic assessment of patients with coronary artery disease by exercise testing. Am Heart J 1983;105:749-755.
10. Dubach P, Froelicher VF, Klein J, Oakes D, Grover-Mckay M, Friis R. Exercise-induced hypotension in a male population. Criteria, causes and prognosis. Circulation 1988;78:1380-1387.
11. Lieberman EB, Heinle SK, Wildermann N, Waugh RA, Kisslo JA, Bashore TM. Does hypotension during dobutamine stress echocardiography correlate with anatomic or functional cardiac impairment? Am Heart J 1995;129:1121-1126.
12. Marcovitz PA, Bach DS, Mathias W, Shayana V, Armstrong WF. Paradoxic hypotension during dobutamine stress echocardiography: Clinical and diagnostic implications. J Am Coll Cardiol 1993;21:1080-1086.
13. Tanimoto M, Pai RG, Jintapakorn W, Shah PM. Mechanism of hypotension during dobutamine stress echocardiography in patients with coronary artery disease. Am J Cardiol 1995;76:26-30.
14. Heinle SK, Tice FD, Kisslo J. Hypotension during stress echocardiography: is it related to dynamic intraventricular obstruction? Am Heart J 1995;130:314-317.
15. Fioretti PM, Brower RW, Simoons ML, ten Kaaten H, Beelen A, Baardman T, Lubsen J, Hugenholtz PG. Relative value of clinical variables, bicycle ergometry, rest radionuclide ventriculography and 24 hour ambulatory electrocardiographic monitoring at discharge to predict 1 year survival after myocardial infarction. J Am Coll Cardiol 1986;8:40-49.
16. Villella A, Maggioni AP, Villella M, Giordano A, Turazza FM, Santoro E, Franzosi GM. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 database. Lancet 1995;346:523-529.
17. Reiber JHC, Serruys PW, Kooijman CJ, Wiins W, Slager CJ, Gerbrands JJ, Suurbiers JC, den Boer A, Hugenholtz PG. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985;71:280-288.
18. Dixon WJ. BMDP Statistical Software. Berkeley, CA: University of California Press, 1992:1105-1144.
19. Pellikka PA, Roger VL, McCully RB, Mahoney DW, Bailey KR, Seward JB, Tajik JA. Normal stroke volume and cardiac output response during dobutamine stress echocardiography in subjects without left ventricular wall motion abnormalities. Am J Cardiol 1995;76:881-886.
20. Tanimoto M, Pai RG, Jintapakorn W. Normal changes in left ventricular filling and hemodynamics during dobutamine stress echocardiography. J Am Soc Echocardiogr 1995;8:488-493.
21. Beleslin BD, Ostojic M, Stepanovic J, Djordjevic-Dikic A, Stojkovic S, Nedeljkovic M, Stankovic G, Petrasinovic Z, Gojkovic L, Vasiljevic-Pokrajcic Z, Nedeljkovic S. Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation 1994;90:1168-1176.
22. Pellikka PA, Oh JK, Bailey KR, Nichols BA, Monahan KH, Tajik JA. Dynamic intraventricular obstruction during dobutamine stress echocardiography. A new observation. Circulation 1992;86:1429-1432.
23. Rosamond TL, Vacek JL, Hurwitz A, Rowland AJ, Beauchamp GD, Crouse LJ. Hypotension during dobutamine stress echocardiography: initial description and clinical relevance. Am Heart J 1992;123:403-407.
24. Weissman NJ, Nidorf SM, Weyman AE, Picard MH. Effect of hydration on cavity obliteration during dobutamine stress echocardiography. Clin Cardiol 1995;18:17-20.
25. Mark AL. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol 1983;11:90-102.
26. Mazeika PK, Nadazdin A, Oakley CM. Clinical significance of abrupt vasodepression during dobutamine stress echocardiography. Am J Cardiol 1992;69:1484-1487.
27. Lakatta EG, Cohen JD, Fleg JL, Frohlich ED, Gradman AH. Hypertension in the elderly: age- and disease-related complications and therapeutic implications. Cardiovasc Drugs Ther 1993:7;643-653.
28. Hogue CW Jr, Dávila-Román VG, Stein PK, Feinberg M, Lappas DG, Pérez JE. Alterations in heart rate variability in patients undergoing dobutamine stress echocardiography, including patients with neurocardiogenic hypotension. Am Heart J 1995;130:1203-1209.